From January 19, 2024 to March 31, 2024, the company has repurchased 1,496,000 shares, representing 0.32% for CNY 84.75 million. With this, the company has completed the repurchase of 1,496,000 shares, representing 0.32% for CNY 84.75 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.35 CNY | -4.84% | -14.49% | -38.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.71% | 2.61B | |
-16.55% | 8.43B | |
+39.49% | 3.62B | |
-8.06% | 2.48B | |
-7.96% | 2.34B | |
-13.97% | 1.94B | |
-19.73% | 1.56B | |
-40.78% | 1.26B | |
+8.32% | 1.1B | |
-10.43% | 1.03B |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.